Literature DB >> 8938729

Differential K+ channel clustering activity of PSD-95 and SAP97, two related membrane-associated putative guanylate kinases.

E Kim1, M Sheng.   

Abstract

The molecular mechanisms underlying the clustering and localization of K+ channels in specific microdomains on the neuronal surface are largely unknown. The Shaker subclass of voltage-gated K+ channel alpha-subunits interact through their cytoplasmic C-terminus with a family of membrane-associated putative guanylate kinases, including PSD-95 and SAP97. We show here that heterologous coexpression of either sap97 or PSD-95 with various Shaker-type subunits results in the coclustering of these proteins with the K+ channels. Mutation of the C-terminal sequence (-ETDV) of the Shaker subunit Kv1.4 abolishes its binding to, and prevents its clustering with, SAP97 and PSD-95. Whereas PSD-95 induces plaque-like clusters of K+ channels at the cell surface; however, SAP97 coexpression results in the formation of large round intracellular aggregates into which both SAP97 and the K+ channel proteins are colocalized. The efficiency of surface clustering by PSD-95 varies with different Shaker subunits: striking Kv1.4 clustering occurs in > 60% of cotransfected cells, whereas Kv1.1 and Kv1.2 form convincing clusters with PSD-95 only in approximately 10% of cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938729     DOI: 10.1016/0028-3908(96)00093-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  39 in total

1.  The contribution of dendritic Kv3 K+ channels to burst threshold in a sensory neuron.

Authors:  A J Rashid; E Morales; R W Turner; R J Dunn
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Ion channel sequestration in central nervous system axons.

Authors:  M N Rasband; P Shrager
Journal:  J Physiol       Date:  2000-05-15       Impact factor: 5.182

3.  Postsynaptic density-93 interacts with the delta2 glutamate receptor subunit at parallel fiber synapses.

Authors:  K W Roche; C D Ly; R S Petralia; Y X Wang; A W McGee; D S Bredt; R J Wenthold
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

Review 4.  Localization and targeting of voltage-dependent ion channels in mammalian central neurons.

Authors:  Helene Vacher; Durga P Mohapatra; James S Trimmer
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

5.  Supertertiary structure of the synaptic MAGuK scaffold proteins is conserved.

Authors:  James J McCann; Liqiang Zheng; Daniel Rohrbeck; Suren Felekyan; Ralf Kühnemuth; R Bryan Sutton; Claus A M Seidel; Mark E Bowen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

Review 6.  Emerging roles of Dlg-like PDZ proteins in the organization of the NMDA-type glutamatergic synapse.

Authors:  T Nagano; H Jourdi; H Nawa
Journal:  J Biochem       Date:  1998-11       Impact factor: 3.387

7.  Migrating transformed MDCK cells are able to structurally polarize a voltage-activated K+ channel.

Authors:  J Reinhardt; N Golenhofen; O Pongs; H Oberleithner; A Schwab
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

8.  The role of PSD-95 in the rearrangement of Kv1.3 channels to the immunological synapse.

Authors:  Orsolya Szilágyi; Anita Boratkó; György Panyi; Péter Hajdu
Journal:  Pflugers Arch       Date:  2013-04-04       Impact factor: 3.657

9.  PSD-95 mediates membrane clustering of the human plasma membrane Ca2+ pump isoform 4b.

Authors:  Rita Padányi; Katalin Pászty; Emanuel E Strehler; Agnes Enyedi
Journal:  Biochim Biophys Acta       Date:  2008-11-27

10.  NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  A Y Chu; J Coresh; D E Arking; J S Pankow; G F Tomaselli; A Chakravarti; W S Post; P H Spooner; E Boerwinkle; W H L Kao
Journal:  Diabetologia       Date:  2009-11-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.